The Predictive Value of PAPP-A for Threatened Miscarriage in Pregnant Women at 11–14 Weeks of Gestation: A Case-Control Study

Background: Pregnancy-associated plasma protein A (PAPP-A) levels in the first trimester of pregnancy are important predictors of future obstetric outcomes. This study evaluated the PAPP-A levels in women with threatened miscarriage and assessed their value in the early diagnosis of this condition. Methods: We conducted a retrospective case-control study from June 2020 to December 2020, involving 122 patients: 61 pregnant women with threatened miscarriage (disease group) and 61 healthy pregnant women (control group). All participants were at gestational age of 11–14 weeks. Pregnant women were selected according to specific diagnostic criteria for threatened miscarriage, regardless of any prior bleeding. The two groups were interviewed to collect data on age, number of pregnancies, body mass index (BMI), risk factors for miscarriage, blood pressure, fetal heart rate, and other relevant parameters. Participants also underwent clinical examinations, including ultrasound scans, non-invasive prenatal testing, and rubella antibody testing. Maternal venous blood samples for PAPP-A quantification were collected at 11–14 gestational weeks. Results: The median PAPP-A concentration was significantly lower in the disease group (0.63 multiples of the median [MoM]) compared to the control group (1.09 MoM), with a p-value < 0.001. Compared to the control group, the disease group exhibited a higher proportion of underweight women (p = 0.024), along with greater gestational age (p = 0.003), crown-rump length (p = 0.005), and nuchal translucency (p = 0.002) values. The PAPP-A levels demonstrated prognostic value in pregnancy, with a cut-off point of 0.8255 MoM for the disease and control groups receiver operating characteristic (ROC) curve analysis demonstrated high sensitivity and relatively high specificity, with an area under the curve (AUC) of 0.789 (p < 0.001). Conclusions: PAPP-A demonstrates moderate predictive value for threatened miscarriage, with low PAPP-A levels being associated with this condition.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Obstetrics & Gynecology
Published
2025-05-22
DOI
https://doi.org/10.31083/ceog28246
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Predictive Value of PAPP-A for Threatened Miscarriage in Pregnant Women at 11–14 Weeks of Gestation: A Case-Control Study

H.V. Ly, H. T. Nguyen, Tam Thai Thanh Tran, Hiếu Trung Phạm et al.
Clinical and Experimental Obstetrics & Gynecology
Pregnancy and preeclampsia studies
article

The Predictive Value of PAPP-A for Threatened Miscarriage in Pregnant Women at 11–14 Weeks of Gestation: A Case-Control Study

H.V. Ly, H. T. Nguyen, Tam Thai Thanh Tran, Hiếu Trung Phạm, H.T. Bui
article en

Abstract

Background: Pregnancy-associated plasma protein A (PAPP-A) levels in the first trimester of pregnancy are important predictors of future obstetric outcomes. This study evaluated the PAPP-A levels in women with threatened miscarriage and assessed their value in the early diagnosis of this condition. Methods: We conducted a retrospective case-control study from June 2020 to December 2020, involving 122 patients: 61 pregnant women with threatened miscarriage (disease group) and 61 healthy pregnant women (control group). All participants were at gestational age of 11–14 weeks. Pregnant women were selected according to specific diagnostic criteria for threatened miscarriage, regardless of any prior bleeding. The two groups were interviewed to collect data on age, number of pregnancies, body mass index (BMI), risk factors for miscarriage, blood pressure, fetal heart rate, and other relevant parameters. Participants also underwent clinical examinations, including ultrasound scans, non-invasive prenatal testing, and rubella antibody testing. Maternal venous blood samples for PAPP-A quantification were collected at 11–14 gestational weeks. Results: The median PAPP-A concentration was significantly lower in the disease group (0.63 multiples of the median [MoM]) compared to the control group (1.09 MoM), with a p-value < 0.001. Compared to the control group, the disease group exhibited a higher proportion of underweight women (p = 0.024), along with greater gestational age (p = 0.003), crown-rump length (p = 0.005), and nuchal translucency (p = 0.002) values. The PAPP-A levels demonstrated prognostic value in pregnancy, with a cut-off point of 0.8255 MoM for the disease and control groups receiver operating characteristic (ROC) curve analysis demonstrated high sensitivity and relatively high specificity, with an area under the curve (AUC) of 0.789 (p < 0.001). Conclusions: PAPP-A demonstrates moderate predictive value for threatened miscarriage, with low PAPP-A levels being associated with this condition.

Clinical and Experimental Obstetrics & GynecologyVol. 52(5)
Can Tho University (VN), Can Tho University of Medicine and Pharmacy
Openalex Percentile: Top 83%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.